U.S. Metals and Mining Stock News

NYSE:FLO
NYSE:FLOFood

Will a Large Non‑Cash Impairment and Dave’s Killer Bread Momentum Change Flowers Foods’ (FLO) Narrative

In the past quarter, Flowers Foods, Inc. recorded a large non-cash impairment charge on intangible assets, prompting investors to reassess its near-term outlook and risk profile. Despite this accounting setback, the company’s Dave’s Killer Bread brand continues to gain share in the organic bread category, highlighting the strength of its premium, health-focused portfolio. We’ll now examine how the sizable non-cash impairment, alongside resilience in Dave’s Killer Bread, affects Flowers...
NasdaqGS:BLKB
NasdaqGS:BLKBSoftware

A Look At Blackbaud (BLKB) Valuation As Development Agent AI Tool Reaches General Availability

Blackbaud (BLKB) just rolled out its Development Agent to Raiser’s Edge NXT customers in the U.S., introducing an AI-powered teammate that can autonomously manage donor outreach under human oversight. See our latest analysis for Blackbaud. Despite rolling out the Development Agent and broadening its AI toolkit, Blackbaud’s 30 day share price return of 10.47% and year to date share price return of 26.18% decline sit alongside a 1 year total shareholder return of 31.23% decline. This points to...
NYSE:JPM
NYSE:JPMBanks

Is It Too Late To Consider JPMorgan Chase (JPM) After Its Strong Multi Year Rally?

For investors wondering whether JPMorgan Chase at around US$286.89 is still offering value or if most of the opportunity is already priced in, this article explores what the current share price might indicate. The stock is roughly flat over the past week with a 0.6% decline, while the 30-day and year-to-date returns of 5.2% and 11.9% declines contrast with a 24.6% gain over 1 year and 135.9% over 3 years. Recent coverage has focused on JPMorgan Chase as a bellwether for large US banks, with...
NasdaqCM:NN
NasdaqCM:NNSoftware

A Look At NextNav (NN) Valuation After Recent Share Price Momentum

What recent performance tells you about NextNav stock NextNav (NN) has attracted fresh attention after recent price moves. The stock closed at US$16.87 and has shown positive returns over the past week, month, and past 3 months, as well as over the past year. See our latest analysis for NextNav. The share price momentum over the past week and month sits on top of a much stronger total shareholder return over one and three years. This suggests that sentiment around NextNav’s growth potential...
NYSE:BCC
NYSE:BCCTrade Distributors

A Look At Boise Cascade (BCC) Valuation After Earnings Beat And Capacity Expansion Plans

What the latest quarterly beat means for Boise Cascade (BCC) Boise Cascade (BCC) recently reported quarterly earnings per share and revenue ahead of analyst estimates, even as seasonal softness and broader market headwinds weighed on the building materials space. The company is also highlighting anticipated growth in its building materials distribution business, recent facility expansions such as the Thorsby i-line project, and steadier engineered wood products pricing as key elements of its...
NasdaqGS:QCOM
NasdaqGS:QCOMSemiconductor

Will Qualcomm’s (QCOM) Bigger Dividend and US$20 Billion Buyback Change Its Capital Allocation Narrative?

Earlier this week, Qualcomm’s board approved an increase in its quarterly cash dividend from US$0.89 to US$0.92 per share, lifting the annual payout to US$3.68, and authorized a new US$20.00 billion share repurchase program with no expiration date. Together, the richer dividend and very large buyback underscore management’s emphasis on returning cash to shareholders while the company pursues diversification beyond its core smartphone chip business. We’ll now examine how Qualcomm’s very large...
NYSE:PAYC
NYSE:PAYCProfessional Services

Is Expanded Buybacks and Credit Capacity Altering The Investment Case For Paycom Software (PAYC)?

Earlier in March 2026, Paycom Software, Inc. expanded its senior secured revolving credit facility to US$1.46 billion, increased its share repurchase authorization to US$2.56 billion remaining, and launched a new Career and Succession Planning tool that integrates talent data across its HCM platform. These moves, alongside stronger-than-expected fourth-quarter 2025 results, a US$0.375 per-share dividend, and an industry award for HR technology innovation, highlight how Paycom is pairing...
NYSE:SHAK
NYSE:SHAKHospitality

Shake Shack’s Alberta Entry Tests Growth Story And Rich Valuation

Shake Shack (NYSE:SHAK) is entering Western Canada with its first Alberta location, expanding its Canadian footprint beyond existing markets. The new restaurant will prioritize Alberta sourced ingredients and community partnerships, including a collaboration with a local artist. The move is positioned as a long term commitment to regional integration, job creation and local engagement. For investors watching NYSE:SHAK, this Alberta opening adds a fresh angle to recent discussions that have...
NYSE:BIP
NYSE:BIPIntegrated Utilities

Brookfield Infrastructure Pivots To AI Data Assets As Valuation Gap Persists

Brookfield Infrastructure Partners (NYSE:BIP) is reshaping its portfolio by rotating out of mature assets and increasing investment in AI factory related data centers and U.S. fiber networks. Management expects the data segment to become one of the partnership's largest business lines, with a rising contribution from digital infrastructure to future revenues. This shift reflects a move toward higher growth infrastructure tied to AI workloads and cloud connectivity. Brookfield Infrastructure...
NasdaqGS:NWL
NasdaqGS:NWLConsumer Durables

Is Newell Brands (NWL) Share Slide Creating A Potential Opportunity For Investors?

If you are wondering whether Newell Brands at around US$3.85 is a bargain or a value trap, the key is understanding what that price actually reflects about the business. The share price has moved sharply in recent periods, with a 9.0% decline over the last 7 days, an 18.1% decline over the past month, a 3.5% gain year to date, and a 37.2% decline over the last year, which will influence how investors think about both risk and potential reward. These swings sit against a backdrop of ongoing...
NYSE:OII
NYSE:OIIEnergy Services

How Insider Selling and Institutional Buying Will Impact Oceaneering International (OII) Investors

On March 11, 2026, Oceaneering International Director M. Mcevoy sold 25,678 shares, while institutional investor Algert Global LLC lifted its stake to 649,747 shares. This mix of insider selling and increased institutional ownership highlights a contrast between board-level share reductions and growing professional investor interest in the company. We’ll now examine how Algert Global’s increased stake might influence Oceaneering International’s existing investment narrative and risk-return...
NYSE:IPI
NYSE:IPIChemicals

A Look At Intrepid Potash (IPI) Valuation After Q4 Turnaround And Lithium Project Update

Intrepid Potash (IPI) has drawn fresh investor attention after reporting fourth quarter 2025 results that reduced its net loss to US$0.429 million and confirming plans to enter lithium production through the White Silver Lithium Project. See our latest analysis for Intrepid Potash. The share price has been building momentum, with a 30 day share price return of 26.71% and a 90 day share price return of 56.14%, while the 1 year total shareholder return sits at 45.02%. This reflects growing...
NasdaqGS:MKSI
NasdaqGS:MKSISemiconductor

How Malaysia Expansion and SBTi Target Validation At MKS (MKSI) Has Changed Its Investment Story

Earlier this month, MKS Inc.’s CEO highlighted at Morgan Stanley’s TMT Conference that the company now serves an estimated 85% of global semiconductor fabrication equipment and 70% of electronics and packaging processes, while also advancing new capacity with a 500,000 square-foot Malaysia facility scheduled to open in mid-2026. Separately, MKS’s short-term greenhouse gas reduction targets received Science Based Targets initiative validation and a board member disclosed a US$72,705 insider...
NYSE:WM
NYSE:WMCommercial Services

Waste Management Highlights CFO Transition And Stericycle Integration For Investors

Waste Management (NYSE:WM) has formally recognized outgoing CFO Devina Rankin for her leadership in integrating the Healthcare Solutions business following the Stericycle acquisition. The acknowledgment also highlights her role in supporting the management transition as the company moves to a new CFO. This recognition underscores the importance of the Stericycle deal and the new Healthcare Solutions segment in Waste Management's business mix. For investors watching NYSE:WM, this leadership...
NasdaqGS:ACLS
NasdaqGS:ACLSSemiconductor

How Axcelis Technologies' (ACLS) Interim CFO Shift May Reframe Its Capital Allocation Narrative

On March 12, 2026, Axcelis Technologies announced that Senior Vice President of Investor Relations and Corporate Strategy David Ryzhik was appointed Interim Chief Financial Officer, replacing departing CFO James Coogan, who will remain until April 24, 2026 to support the handover. The move places a long‑tenured finance and investor relations specialist at the center of Axcelis’s financial leadership, potentially sharpening how the company aligns capital allocation, messaging, and corporate...
NasdaqGS:ZS
NasdaqGS:ZSSoftware

Should Zscaler’s (ZS) Data Sovereignty Push Redefine Its Role in Compliance-Driven Cybersecurity?

Earlier this month, Zscaler expanded its global data sovereignty capabilities on the Zero Trust Exchange, adding new regional control and logging planes, in-region SSL inspection and malware analysis, and options for local or on-premises log storage to help customers keep sensitive data within required jurisdictions. This push toward a more decentralized, jurisdiction-aware cloud architecture, backed by third-party validation and customer-controlled encryption keys, could make Zscaler’s...
NYSE:WAB
NYSE:WABMachinery

How Wabtec’s Strong Q4 Beat And Confident 2026 Outlook At Westinghouse Air Brake Technologies (WAB) Has Changed Its Investment Story

Westinghouse Air Brake Technologies recently reported a stronger-than-expected fourth-quarter 2025 performance and reaffirmed confident 2026 guidance, emphasizing double-digit adjusted EPS growth, record cash generation, and support from a multi-year backlog despite industry headwinds. Around the same time, Executive Vice President of Sales & Marketing Gina Trombley sold 4,013 shares, highlighting ongoing insider selling that contrasts with the company’s upbeat operational outlook. Next,...
NasdaqGS:CYTK
NasdaqGS:CYTKBiotechs

New Aficamten HCM Data On Exercise Capacity And Flexibility Might Change The Case For Investing In Cytokinetics (CYTK)

Cytokinetics recently announced that four presentations on MYQORZO™ (aficamten) for symptomatic obstructive hypertrophic cardiomyopathy were delivered at the American College of Cardiology 2026 Annual Scientific Session, highlighting new analyses from the SEQUOIA-HCM, MAPLE-HCM, and FOREST-HCM trials. The data underscored that aficamten improved exercise capacity versus placebo and metoprolol, maintained efficacy across patients with and without hypertension, and showed reassuring safety...
NYSE:DTE
NYSE:DTEIntegrated Utilities

Is It Time To Reassess DTE Energy (DTE) After Its Recent Share Price Strength

To put DTE Energy in context, you need to decide whether the current share price reflects fair value, a potential opportunity, or a risk of overpaying. DTE Energy's share price closed at US$149.34, with total returns of 1.1% over 7 days, 3.0% over 30 days, 14.6% year to date, 14.0% over 1 year, 55.8% over 3 years and 60.5% over 5 years. This gives you a useful snapshot of how the stock has behaved over different time frames. Recent company specific news has focused on DTE Energy's role as a...
NasdaqGS:ZION
NasdaqGS:ZIONBanks

Fraud Probe Into California Loan Misstatements Might Change The Case For Investing In Zions (ZION)

Zions Bancorporation, N.A. recently became the focus of a securities fraud investigation after disclosing apparent misrepresentations and contractual defaults on two commercial and industrial loans in its California Bank & Trust division, prompting full provisioning and significant charge‑offs. At the same time, Zions is hosting a fraud prevention conference and has taken a lead role arranging a US$490 million credit facility for Varex Imaging, underscoring its dual position as both a risk...
NYSE:MKL
NYSE:MKLInsurance

How Markel’s New Analytics Chief Could Reshape Risk Selection and Pricing for Markel Group (MKL) Investors

On March 10, 2026, Markel Insurance appointed Kristen Dardia as Head of Portfolio Analytics for the US and Bermuda, tasking her with leading advanced analytics, technical pricing, and portfolio management after nearly two decades in actuarial science, analytics, and business strategy. Her track record embedding analytics into underwriting and portfolio decisions could meaningfully influence how Markel Group refines risk selection and pricing across its specialty insurance operations. Next,...
NasdaqGS:CSX
NasdaqGS:CSXTransportation

CSX Select Site Growth And Owens Corning Deal Shape Valuation View

CSX expanded its Select Site initiative by awarding its designation to 21 new rail served properties across 10 states. Owens Corning announced a large manufacturing investment at a CSX Silver Select Site in Alabama, tied to about 100 new skilled jobs. This development reflects fresh industrial interest in CSX served locations, beyond recent discussions focused on valuation, margin outlook, and service metrics for NasdaqGS:CSX. For investors tracking NasdaqGS:CSX, this move adds a fresh...
NasdaqGS:PODD
NasdaqGS:PODDMedical Equipment

Assessing Insulet (PODD) Valuation After Omnipod 5 Tubing Defect And Ongoing Product Replacements

Insulet (PODD) is in focus after disclosing an internal tubing defect in certain Omnipod 5 Pod lots, prompting a voluntary Medical Device Correction and free replacements. Production and new patient starts are expected to continue. See our latest analysis for Insulet. The tubing defect news has landed against a weak recent share price backdrop, with the 90 day share price return at a 20.4% decline and the 1 year total shareholder return at an 11.5% loss. This suggests that momentum has been...
NasdaqCM:ALDX
NasdaqCM:ALDXBiotechs

Aldeyra Therapeutics (ALDX) Is Down 75.2% After FDA Rebuffs Dry Eye Drug Efficacy Data - Has The Bull Case Changed?

In March 2026, Aldeyra Therapeutics reported that the FDA issued a Complete Response Letter for its reproxalap dry eye disease NDA, citing insufficient and inconsistent evidence of efficacy despite no safety or manufacturing concerns. An important nuance is that the FDA did not request new trials, instead urging Aldeyra to clarify why certain studies failed and where reproxalap might work best. We’ll now examine how the FDA’s efficacy concerns and lack of requested new trials reshape...